S03297 Summary:

BILL NOS03297
 
SAME ASSAME AS A05995
 
SPONSORHOYLMAN-SIGAL
 
COSPNSRMYRIE, SALAZAR
 
MLTSPNSR
 
Amd §§6527, 6909 & 6801, Ed L
 
Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.
Go to top    

S03297 Actions:

BILL NOS03297
 
01/30/2023REFERRED TO HIGHER EDUCATION
01/03/2024REFERRED TO HIGHER EDUCATION
Go to top

S03297 Committee Votes:

Go to top

S03297 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S03297 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          3297
 
                               2023-2024 Regular Sessions
 
                    IN SENATE
 
                                    January 30, 2023
                                       ___________
 
        Introduced  by  Sens.  HOYLMAN-SIGAL,  MYRIE,  SALAZAR -- read twice and
          ordered printed, and when printed to be committed to the Committee  on
          Higher Education
 
        AN  ACT  to  amend the education law, in relation to authorizing pharma-
          cists to dispense HIV pre-exposure and post-exposure prophylaxis

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivision  7-a of section 6527 of the education law, as
     2  added by chapter 502 of the laws of 2016, is amended to read as follows:
     3    7-a. A licensed physician may prescribe and order a  patient  specific
     4  order  or  non-patient specific order to a licensed pharmacist, pursuant
     5  to regulations promulgated by the commissioner in consultation with  the
     6  commissioner  of  health, and consistent with the public health law, for
     7  dispensing up to a seven day starter pack of HIV  post-exposure  prophy-
     8  laxis  for  the  purpose  of  preventing  human  immunodeficiency  virus
     9  infection following a potential human immunodeficiency virus exposure. A
    10  licensed physician may also prescribe and order a  patient  specific  or
    11  non-patient  specific  order to a licensed pharmacist, pursuant to regu-
    12  lations promulgated by the commissioner in consultation with the commis-
    13  sioner of health, and consistent with the public health law and  section
    14  sixty-eight hundred one of this title, for HIV pre-exposure prophylaxis,
    15  provided,  however,  that  the  regulations promulgated pursuant to this
    16  subdivision shall require that the HIV pre-exposure prophylaxis  author-
    17  ized to be dispensed by a licensed pharmacist shall provide for at least
    18  a thirty-day, but no more than a sixty-day, supply of such prophylaxis.
    19    §  2.  Subdivision 8 of section 6909 of the education law, as added by
    20  chapter 502 of the laws of 2016, is amended to read as follows:
    21    [8.] 11. A certified nurse practitioner  may  prescribe  and  order  a
    22  patient specific order or non-patient specific order to a licensed phar-
    23  macist,  pursuant  to  regulations  promulgated  by  the commissioner in
    24  consultation with the commissioner of health, and  consistent  with  the
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01383-02-3

        S. 3297                             2
 
     1  public  health law, for dispensing up to a seven day starter pack of HIV
     2  post-exposure prophylaxis for the purpose of preventing human  immunode-
     3  ficiency  virus  infection  following a potential human immunodeficiency
     4  virus  exposure.  A  certified nurse practitioner may also prescribe and
     5  order a patient specific or non-patient specific  order  to  a  licensed
     6  pharmacist,  pursuant  to regulations promulgated by the commissioner in
     7  consultation with the commissioner of health, and  consistent  with  the
     8  public health law and section sixty-eight hundred one of this title, for
     9  HIV  pre-exposure  prophylaxis,  provided, however, that the regulations
    10  promulgated pursuant to this subdivision  shall  require  that  the  HIV
    11  pre-exposure  prophylaxis authorized to be dispensed by a licensed phar-
    12  macist shall provide for at least a  thirty-day,  but  no  more  than  a
    13  sixty-day, supply of such prophylaxis.
    14    §  3.  Subdivision 5 of section 6801 of the education law, as added by
    15  chapter 502 of the laws of 2016, is amended and a new subdivision  9  is
    16  added to read as follows:
    17    5. A licensed pharmacist may execute a non-patient specific order, for
    18  dispensing  up  to a seven day starter pack of HIV post-exposure prophy-
    19  laxis medications for the purpose of preventing  human  immunodeficiency
    20  virus  infection, by a physician licensed in this state or nurse practi-
    21  tioner certified in  this  state,  pursuant  to  rules  and  regulations
    22  promulgated by the commissioner in consultation with the commissioner of
    23  health  following a potential human immunodeficiency virus exposure. The
    24  pharmacist shall also inform the patient of the availability of  pre-ex-
    25  posure  prophylaxis for persons who are at substantial risk of acquiring
    26  HIV.
    27    9. A licensed pharmacist may execute a non-patient specific order, for
    28  dispensing HIV pre-exposure prophylaxis, pursuant  to  rules  and  regu-
    29  lations promulgated by the commissioner in consultation with the commis-
    30  sioner  of  health  provided,  however,  that  the rules and regulations
    31  promulgated pursuant to this subdivision  shall  require  that  the  HIV
    32  pre-exposure  prophylaxis authorized to be dispensed by a licensed phar-
    33  macist shall provide for at least a  thirty-day,  but  no  more  than  a
    34  sixty-day,  supply  of such prophylaxis. And provided, further, that the
    35  following conditions shall be met before a pharmacist may dispense  pre-
    36  exposure prophylaxis:
    37    (a)  The  pharmacist  has  completed a training program created by the
    38  department of health on the use of pre-exposure prophylaxis. The  train-
    39  ing  program  shall  educate  pharmacists about the requirements of this
    40  subdivision, the risks and  side  effects  of  the  medication,  patient
    41  insurance  and  cost  burdens, and any other information such department
    42  deems necessary or important;
    43    (b) The patient is HIV negative, as documented by a negative HIV  test
    44  result   obtained   within   the   previous   seven  days  from  an  HIV
    45  antigen/antibody test or antibody-only test or from a  rapid,  point-of-
    46  care fingerstick blood test approved by the federal food and drug admin-
    47  istration.  If  the  patient does not provide evidence of a negative HIV
    48  test in accordance with this paragraph, the pharmacist may recommend  an
    49  HIV  test.  If the patient tests positive for HIV infection, the pharma-
    50  cist shall direct the patient to a licensed physician  and  provide  the
    51  patient  with a list of health care service providers and clinics within
    52  the county where the pharmacist is located or adjacent counties;
    53    (c) The patient does not report any signs or  symptoms  of  acute  HIV
    54  infection  on a self-reported checklist of acute HIV infection signs and
    55  symptoms;

        S. 3297                             3
 
     1    (d) The patient does not report  taking  any  contraindicated  medica-
     2  tions;
     3    (e)  The  pharmacist  does not furnish more than a sixty-day supply of
     4  pre-exposure prophylaxis to a single patient more than  once  every  two
     5  years, unless directed otherwise by a prescriber.
     6    (f)  The  pharmacist  provides  written  information, published by the
     7  department of health, to the patient on the ongoing use of  pre-exposure
     8  prophylaxis,  which  may  include  education  about side effects, safety
     9  during pregnancy and breastfeeding, adherence to recommended dosing, and
    10  the importance of timely testing and treatment, as applicable, for  HIV,
    11  renal function, hepatitis B, hepatitis C, sexually transmitted diseases,
    12  and  pregnancy for individuals of child-bearing capacity. The pharmacist
    13  shall notify the patient that the patient must be  seen  by  a  licensed
    14  physician  to  receive subsequent prescriptions for pre-exposure prophy-
    15  laxis; and
    16    (g) The pharmacist provides information, with the  patient's  consent,
    17  to  the patient or, when the patient lacks capacity to consent, a person
    18  authorized to consent to health care for such individual, on the  impor-
    19  tance of having a health care provider, developed by the commissioner of
    20  health,  and  if  the  patient  does not have a health care provider the
    21  pharmacist shall provide the patient  a  list  of  licensed  physicians,
    22  clinics,  or other health care service providers within the county where
    23  the pharmacist is located or adjacent counties.
    24    § 4. This act shall take effect on the one hundred eightieth day after
    25  it shall have become a law. Effective immediately, the addition,  amend-
    26  ment and/or repeal of any rule or regulation necessary for the implemen-
    27  tation  of  this act on its effective date are authorized to be made and
    28  completed on or before such date.
Go to top